MorphoSys Ag
(ETR) MOR
MorphoSys Ag Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$203.58M
Net Income (TTM)
$460.26M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MOR News
MOR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MorphoSys Ag
Industry
Biotechnology
Sector
Health CareEmployees
446
CEO
Arkadius Pichota
Website
www.morphosys.deHeadquarters
Planegg, 82152, DE
MOR Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
-1%
Net Income Margin
-80%
Return on Equity
-2%
Return on Capital
-14%
Return on Assets
-9%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$179.92M
Operating Income
$252.48M
EBITDA
$235.42M
Operating Cash Flow
$295.84M
Capital Expenditure
$2.87M
Free Cash Flow
$298.71M
Cash & ST Invst.
$682.76M
Total Debt
$635.93M
MorphoSys Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$27.54M
-55.8%
Gross Profit
$23.67M
-42.7%
Gross Margin
85.96%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
464
N/A
Net Income
$314.96M
-617.7%
EBITDA
$307.29M
-1135444.8%
Quarterly Fundamentals
Net Cash
$369.74M
-27.6%
Accounts Receivable
$30.83M
-60.5%
Inventory
$0.00
-100.0%
Long Term Debt
$246.67M
-10.3%
Short Term Debt
$5.80M
-3.6%
Return on Assets
-9.36%
N/A
Return on Invested Capital
-14.33%
N/A
Free Cash Flow
$64.47M
+10.0%
Operating Cash Flow
$64.43M
+9.6%